Related Experiment Video

Updated: Aug 19, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

[Pathogenesis of acute myocardial infarction. I. Complement activation in vivo and development of infarction]

P A Reyes, G Fernández de la Reguera, C Enríquez

    Archivos Del Instituto De Cardiologia De Mexico
    |July 1, 1984
    PubMed

    Insights

    Complement activation, indicated by C3 split products, is present in 30% of acute myocardial infarction patients. This in vivo complement activation correlates with infarction severity, suggesting its role in heart attack progression.

    Area of Science:

    • Biochemistry
    • Immunology
    • Cardiology

    Context:

    • Acute myocardial infarction (AMI) is a leading cause of mortality.
    • The role of the complement system in AMI pathogenesis requires further elucidation.
    • Complement split products can indicate in vivo complement activation.

    Purpose:

    • To investigate the presence of complement split products in patients with acute myocardial infarction.
    • To determine if complement activation correlates with the severity of myocardial infarction.

    Summary:

    • This study analyzed plasma from 53 AMI patients and 25 healthy controls.
    • Complement split products (specifically C3 degradation products) were detected in 30% of AMI patients, versus 8% of controls.
    • The presence of these products indicated in vivo complement activation and correlated with infarction severity.

    Impact:

    • These findings suggest that in vivo complement activation is a significant factor in acute myocardial infarction.
    • Identifying complement activation markers could lead to novel diagnostic or therapeutic strategies for AMI.

    More Related Videos

    Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery08:38

    Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

    Published on: August 16, 2019

    Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction05:48

    Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction

    Published on: August 9, 2022

    Related Concept Videos

    Complement System01:27

    Complement System

    The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Ischemic Stroke ll: Pathophysiology01:15

    Ischemic Stroke ll: Pathophysiology

    An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...